Vivo is all set to enter the pill section within the first half of 2022. This was first talked about by Vivo’s Government Vice President Hu Baishan throughout an interview in August. The corporate had additionally trademarked “Vivo Pad” with the European Union Mental Property Workplace (EUIPO) in June beneath Class 9, which covers, amongst many merchandise, tablets and PDAs. Whereas we look ahead to an official replace from Vivo, a recognized tipster has claimed that Vivo is predicted to launch a pill with a Qualcomm Snapdragon chipset.
Tipster Digital Chat Station has posted on Weibo that Vivo can be launching a pill with a Snapdragon 870 SoC. A Vivo gadget that was noticed on TÜV Rheinland certification web site not too long ago is imagined to be this upcoming pill. It means that the aforementioned gadget goes to be geared up with an 8,040mAh battery.
Different main smartphone producers are additionally tipped to enter the pill market, together with Oppo and OnePlus.
The identify “OnePlus Pad” was trademarked with the EUIPO in July. Moreover, a not too long ago surfaced picture is believed to supply extra particulars in regards to the rumoured Oppo pill. In accordance with Digital Chat Station, the Oppo pill can be powered by a Snapdragon 870 SoC paired with 6GB of RAM and 256GB of storage. It’s stated to run on the Android 11-based ColorOS 12 and options an 8,080mAh battery. The pill is alleged to have an 11-inch LCD display with a 120Hz refresh price and a decision of two,560×1,600 pixels. Moreover, the tipster claims that the pill can be geared up with a 13-megapixel main digital camera and an 8-megapixel entrance shooter.
Whereas its sister manufacturers are nonetheless competing to enter the section, Realme was the primary BBK Electronics model to have launched its pill in September this yr. Realme Pad includes a MediaTek Helio G80 chip with 4GB of RAM and 64GB of Storage. It has 8-megapixel cameras on the entrance and the again. Additionally, the pill is fitted with a 7,100mAh battery.